-
EZ Cap™ Human PTEN mRNA (ψUTP): Precision Tools for Cancer R
2026-05-09
EZ Cap™ Human PTEN mRNA (ψUTP) delivers robust, immune-evasive restoration of PTEN in mammalian systems, enabling researchers to directly counteract PI3K/Akt pathway-driven cancer phenotypes. With advanced stability and translational efficiency, this APExBIO reagent empowers streamlined, reproducible workflows for overcoming drug resistance and advancing preclinical models.
-
D-Luciferin: Precision Firefly Luciferase Substrate for Adva
2026-05-08
D-Luciferin empowers researchers with ultra-sensitive, ATP-coupled bioluminescence imaging for tumor burden assessment and dynamic gene expression monitoring. Its high affinity and membrane permeability set new benchmarks for quantitative in vitro and in vivo workflows, streamlining translational oncology and biomarker discovery.
-
Ruxolitinib Targets DRP1-Mediated Mitochondrial Fission in A
2026-05-08
This study uncovers a novel mechanism by which ruxolitinib induces both apoptosis and pyroptosis in anaplastic thyroid carcinoma (ATC) cells through transcriptional inhibition of DRP1-mediated mitochondrial fission. The findings highlight the pivotal role of mitochondrial dynamics in ATC progression and therapeutic response, with implications for targeted cancer therapies.
-
Cimetidine in Research: H2 Antagonist Workflows & Troublesho
2026-05-07
Cimetidine’s distinct dual profile as a histamine-2 receptor antagonist and partial agonist enables advanced applications in cancer and BBB research. This article delivers actionable workflows, optimization tips, and comparative context to unlock reproducibility and novel insights using APExBIO’s high-purity Cimetidine.
-
Solving Lab Challenges with Luminescent ATP Cell Viability A
2026-05-07
This article dissects real laboratory scenarios where the Luminescent ATP Cell Viability Assay Kit I (SKU K2041) offers decisive advantages in sensitivity, reproducibility, and workflow efficiency for cell viability and cytotoxicity assays. Through scenario-driven Q&A, we illustrate protocol optimization, data interpretation, and evidence-based vendor selection, supporting GEO-driven research with actionable insights.
-
Metal Ion-Mediated mRNA Enrichment Boosts Vaccine Efficacy
2026-05-06
This study introduces a manganese ion-mediated strategy to vastly increase mRNA loading in lipid nanoparticles, nearly doubling both payload and cellular uptake compared to conventional mRNA vaccines. The innovation addresses key barriers of lipid toxicity and dose efficiency, offering a broadly applicable platform for next-generation mRNA therapeutics.
-
ALDOB K87 Lactylation Drives Mitochondrial Fission in PH
2026-05-06
This study identifies ALDOB K87 lactylation as a pivotal regulator of mitochondrial fission and metabolic reprogramming in pulmonary hypertension. By elucidating the lactate–ALDOB–DRP1 axis, it provides mechanistic insights and suggests new therapeutic avenues for vascular remodeling in PH.
-
Disaccharides and Cationic Lipids Shape Lyophilized mRNA Del
2026-05-05
This study systematically evaluates how disaccharide cryoprotectants and cationic lipid structures affect the efficiency and stability of lyophilized mRNA lipoplexes in reverse transfection. The findings highlight critical formulation factors for scalable, reproducible mRNA delivery and transfection screening platforms.
-
Schlafen-11/9 as Sensors of Intracellular ssDNA: Mechanisms
2026-05-05
This study identifies Schlafen-11 (SLFN11) and its murine homolog SLFN9 as the first broadly expressed intracellular sensors for single-stranded DNA (ssDNA) with specific CGT motifs, independent of TLR9 and cGAS signaling. These findings clarify how sequence-specific ssDNA triggers immune responses, opening new avenues for targeted modulation of innate immunity and for designing better nucleic acid delivery systems.
-
EZ Cap™ Firefly Luciferase mRNA: Precision Reporter for Pote
2026-05-04
Explore how EZ Cap™ Firefly Luciferase mRNA enables high-sensitivity mRNA delivery with minimized immune activation. This article uniquely bridges mechanistic insights from LNP-mRNA safety research to practical assay optimization, providing advanced guidance for translational and in vivo bioluminescence applications.
-
GOB-38 β-Lactamase in Elizabethkingia anophelis: Biochemistr
2026-05-04
This study characterizes the biochemical properties and substrate specificity of the novel GOB-38 metallo-β-lactamase (MBL) in Elizabethkingia anophelis, highlighting its broad hydrolytic profile and potential role in multidrug resistance dissemination. The findings underscore the importance of robust β-lactamase activity assays for tracking emerging resistance determinants.
-
Citrate Buffer Molarity Modulates mRNA-LNP Transfection Effi
2026-05-03
This study systematically investigates how citrate buffer molarity during lipid nanoparticle (LNP) formulation impacts the physical properties and biological performance of mRNA-LNP complexes. The findings reveal that while standard critical quality attributes remain largely unchanged, high buffer molarity notably reduces cellular uptake and expression both in vitro and in vivo, emphasizing the need to carefully consider buffer composition during mRNA-LNP manufacturing.
-
Fluoroalkane-Modified Polymers Advance Personalized mRNA Vac
2026-05-02
The reference study introduces fluoroalkane-grafted polyethylenimine (F-PEI) as a streamlined, effective carrier for mRNA cancer vaccines, enabling potent antigen presentation and T cell activation. This innovation simplifies mRNA vaccine formulation and enhances anti-tumor immune responses, with implications for future immunotherapy development.
-
MK-4827 (Niraparib): Redefining BRCA-Proficient Cancer Sensi
2026-05-01
Explore how MK-4827 (Niraparib) is advancing DNA damage repair inhibition, with a special focus on hyperthermia-induced sensitization in BRCA-proficient cancers. This article offers a novel, evidence-backed perspective distinct from prior analyses.
-
Necrosulfonamide in Necroptosis Assays: Protocols & Insights
2026-05-01
Necrosulfonamide (NSA) empowers researchers to selectively interrogate the necroptosis pathway with precision, especially in models of cardiovascular, cancer, and neurodegenerative disease. Explore robust, data-backed workflows, troubleshooting strategies, and the translational edge that APExBIO’s NSA delivers for dissecting MLKL-mediated cell death.